Ligand Pharmaceuticals
LGND
#4143
Rank
โ‚น184.72 B
Marketcap
โ‚น9,776
Share price
0.61%
Change (1 day)
66.03%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2024 (TTM): โ‚น12.72 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น12.99 Billion. In 2023 the company made a revenue of โ‚น10.93 Billion a decrease over the revenue in the year 2022 that were of โ‚น14.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น12.72 B16.38%
2023 โ‚น10.93 B-23.6%
2022 โ‚น14.30 B-30.64%
2021 โ‚น20.62 B51.3%
2020 โ‚น13.63 B58.95%
2019 โ‚น8.57 B-51.22%
2018 โ‚น17.58 B95.15%
2017 โ‚น9.00 B21.66%
2016 โ‚น7.40 B54.96%
2015 โ‚น4.77 B16.84%
2014 โ‚น4.09 B35.19%
2013 โ‚น3.02 B76.05%
2012 โ‚น1.71 B8.16%
2011 โ‚น1.58 B50.64%
2010 โ‚น1.05 B-41.63%
2009 โ‚น1.80 B37.63%
2008 โ‚น1.31 B159.45%
2007 โ‚น0.50 B-84.73%
2006 โ‚น3.31 B-55.06%
2005 โ‚น7.37 B7.37%
2004 โ‚น6.86 B6.86%
2003 โ‚น6.42 B38.66%
2002 โ‚น4.63 B25.81%
2001 โ‚น3.68 B61.81%
2000 โ‚น2.27 B28.14%
1999 โ‚น1.77 B136.05%
1998 โ‚น0.75 B-62.96%
1997 โ‚น2.03 B52.75%
1996 โ‚น1.33 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.774 T 21,244.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.19 B-83.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.432 T 26,308.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น5.387 T 41,346.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.126 T 39,337.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.484 T 26,709.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.045 T 31,020.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.192 T 9,077.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.478 T 57,435.00%๐Ÿ‡บ๐Ÿ‡ธ USA